GR3006111T3 - - Google Patents

Info

Publication number
GR3006111T3
GR3006111T3 GR920402432T GR920402432T GR3006111T3 GR 3006111 T3 GR3006111 T3 GR 3006111T3 GR 920402432 T GR920402432 T GR 920402432T GR 920402432 T GR920402432 T GR 920402432T GR 3006111 T3 GR3006111 T3 GR 3006111T3
Authority
GR
Greece
Prior art keywords
range
formulations
drug
concentration
physiologically acceptable
Prior art date
Application number
GR920402432T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006111T3 publication Critical patent/GR3006111T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920402432T 1987-02-05 1992-10-29 GR3006111T3 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/011,016 US4863714A (en) 1987-02-05 1987-02-05 Sterilization of compositions of limited stability

Publications (1)

Publication Number Publication Date
GR3006111T3 true GR3006111T3 (https=) 1993-06-21

Family

ID=21748489

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402432T GR3006111T3 (https=) 1987-02-05 1992-10-29

Country Status (9)

Country Link
US (1) US4863714A (https=)
EP (1) EP0278674B1 (https=)
JP (1) JPH0667855B2 (https=)
AT (1) ATE79279T1 (https=)
AU (1) AU607461B2 (https=)
CA (1) CA1300005C (https=)
DE (1) DE3873553T2 (https=)
ES (1) ES2034184T3 (https=)
GR (1) GR3006111T3 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4015832A1 (de) * 1990-05-17 1991-11-21 Thomae Gmbh Dr K Verfahren zur inaktivierung der biologischen aktivitaet von dna
AU701724B2 (en) * 1994-07-01 1999-02-04 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US7122210B2 (en) 2002-01-11 2006-10-17 Baxter International Inc. Bicarbonate-based solutions for dialysis therapies
US7445801B2 (en) * 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
US7935070B2 (en) * 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
JPWO2008146731A1 (ja) * 2007-05-25 2010-08-19 味の素株式会社 末梢静脈投与用輸液の製造方法
KR101915821B1 (ko) * 2010-03-23 2018-11-06 지이 헬스케어 에이에스 안정화된 ｘ―선 진단용 조성물의 제조
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224440A (en) * 1975-05-15 1980-09-23 Mallinckrodt, Inc. 1-(3,5-Disubstituted-2,4,6-triiodophenly)-3-(polyhydroxy-alkyl)urea compounds
AT371998B (de) * 1978-07-04 1983-08-25 Nyegaard & Co As Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels
GB2031405B (en) * 1978-07-04 1983-06-15 Nyegaard & Co As Process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
FR2571367B1 (fr) * 1984-10-09 1987-02-13 Guerbet Sa Composes triaminobenzeniques iodes et/ou bromes, leur procede de preparation et leur application dans des produits de contraste
GB8717625D0 (en) * 1987-07-24 1987-09-03 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
JPH0667855B2 (ja) 1994-08-31
AU1133688A (en) 1988-08-11
EP0278674A2 (en) 1988-08-17
DE3873553D1 (de) 1992-09-17
ES2034184T3 (es) 1993-04-01
US4863714A (en) 1989-09-05
DE3873553T2 (de) 1993-02-18
EP0278674A3 (en) 1989-07-19
ATE79279T1 (de) 1992-08-15
AU607461B2 (en) 1991-03-07
JPH01221330A (ja) 1989-09-04
EP0278674B1 (en) 1992-08-12
CA1300005C (en) 1992-05-05

Similar Documents

Publication Publication Date Title
GR3006111T3 (https=)
US4740373A (en) Stabilization of multivitamin/trace elements formulations
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
KR19990063978A (ko) 안정한 파라세타몰 기재 액체 제형 및 이들을 제조하기 위한방법
ES2186737T3 (es) Composiciones de oxicodona de liberacion controlada.
DE3468082D1 (en) Heat sterilizable storage solution for red blood cells and blood bags containing it
AU688803B2 (en) Method for treatment for pulmonary disease
GEP19971155B (en) Contrast medium and method for its production
HUT65208A (en) Lowering blood cholesterol levels using pharmaceutical compositions with cellulose ethers as active agent
GR3004869T3 (https=)
US4804535A (en) Stabilization of multivitamin/trace elements formulations
Hatch et al. Effect of megadoses of ascorbic acid on serum and urinary oxalate
US4883805A (en) Stable, Injectable solutions of vinca dimer salts
DE3162614D1 (en) Dibenzoxazepine derivative, process for preparing the same and pharmaceutical composition comprising the same
HUT49808A (en) Process for producing retarde pharmaceutical compositions containing aselastine
GB2021946A (en) Pharmaceutical Formulations Containing Cis-platinum (II) Diamminedichloride
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
EP0229963A3 (en) 4-thienyl-dihydropyridines, process for their preparation and their use as pharmaceutical preparations
HU9202229D0 (en) Method for manufacturing new pharmaceutical preparatives containing 2-oxo-benzimidaazoline-1-carboxylic acid derivatives
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
WEI Mitomycin-C eyedrops for the prevention of postoperative recurrence of pterygium
HUT38607A (en) Process for producing phenyl-ethyl-amino-propiophenone derivatives and pharmaceutical composition containing them as active agents
NO155620C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.
ATE90204T1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.